The Place of In Vitro Maturation in PCO/PCOS

In vitro maturation (IVM) of human oocytes is an emerging treatment option for women with polycystic ovary/polycystic ovary syndrome (PCO/PCOS) in addition to the standard in vitro fertilization (IVF) treatment. There has been significant improvements in pregnancy rates with IVM over the last two de...

Full description

Saved in:

Bibliographic Details
Published in:	International journal of endocrinology Vol. 2018; no. 2018; pp. 1 - 8
Main Authors:	Julania, Shital, Hart, Roger, Walls, Melanie L.
Format:	Journal Article
Language:	English
Published:	Cairo, Egypt Hindawi Publishing Corporation 01-01-2018 Hindawi John Wiley & Sons, Inc Hindawi Limited
Subjects:	Care and treatment Embryos Endocrinology Fertility In vitro fertilization Infertility Laboratories Oophorectomy Ovaries Ovulation Polycystic ovary syndrome Pregnancy Review Stein-Leventhal syndrome Womens health Australia
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	In vitro maturation (IVM) of human oocytes is an emerging treatment option for women with polycystic ovary/polycystic ovary syndrome (PCO/PCOS) in addition to the standard in vitro fertilization (IVF) treatment. There has been significant improvements in pregnancy rates with IVM over the last two decades. This article reviews the place of IVM for women with PCO/PCOS, placing an emphasis on the predictors of successful pregnancy, optimization of culture media, IVM protocols, pregnancy rates, and neonatal outcomes following IVM treatment.
Bibliography:	ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 Academic Editor: Antonio Simone Laganà
ISSN:	1687-8337 1687-8345
DOI:	10.1155/2018/5750298